Brief: Nicox's Partner Ocumension Therapeutics Initiates Zerviate Phase 3 Clinical Trial In China

Nicox SA

30/12/2020 06:33

Dec 30 (Reuters) - Nicox SA  NCOX.PA :
    * NICOX'S PARTNER OCUMENSION THERAPEUTICS INITIATES ZERVIATE PHASE 3
CLINICAL
TRIAL IN CHINA
    * THIS PHASE 3 TRIAL, IN ADDITION TO DATA PACKAGE USED BY FDA FOR ZERVIATE
IN
UNITED STATES, IS EXPECTED TO BE SUFFICIENT TO SUPPORT A CHINESE NEW DRUG
APPLICATION

Source text for Eikon:  ID:nGNE6FLkBB 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))